Amendment Statement of Principles concerning sarcoidosis (Balance of Probabilities) (No. 14 of 2019)

Administered by Department of Veterans' Affairs

Legislation au F2019L00004 Not in force Legislative Instrument

Legislation content

EXPLANATORY STATEMENT

 

AMENDMENT Statement of Principles concerning

SARCOIDOSIS

(BALANCE OF PROBABILITIES) (NO. 14 OF 2019)

 

VETERANS' ENTITLEMENTS ACT 1986

MILITARY REHABILITATION AND COMPENSATION ACT 2004

 

  1. This is the Explanatory Statement to the Amendment Statement of Principles concerning sarcoidosis (Balance of Probabilities) (No. 14 of 2019).

Background

2.             The Repatriation Medical Authority (the Authority) has determined, under subsections 196B(3) and (8) of the Veterans' Entitlements Act 1986 (the VEA) Amendment Statement of Principles concerning sarcoidosis (Balance of Probabilities) (No. 14 of 2019).

3.             This Instrument amends Statement of Principles concerning sarcoidosis (Balance of Probabilities) (No. 60 of 2016) (Federal Register of Legislation No. F2016L01143) by:

  • replacing the existing factors in subsections 9(1) & 9(3) concerning 'being treated with a drug';
  • inserting a definition of 'specified list of drugs' in Schedule 1 – Dictionary.

Day of Commencement

4.             This Instrument also specifies a day of commencement for the amendment in accordance with subsection 12(3) of the Legislation Act 2003.

Consultation

5.             Prior to determining this Instrument, the Authority advertised its intention to undertake an investigation in relation to sarcoidosis in the Government Notices Gazette of 4 September 2018, and circulated a copy of the notice of intention to investigate to a wide range of organisations representing veterans, service personnel and their dependants.  The Authority invited submissions from the Repatriation Commission, the Military Rehabilitation and Compensation Commission, organisations and persons referred to in section 196E of the VEA, and any person having expertise in the field.  One submission was received for consideration by the Authority during the investigation.

Human Rights

6.             This instrument is compatible with the Human Rights and Freedoms recognised or declared in the International Instruments listed in Section 3 of the Human Rights (Parliamentary Scrutiny) Act 2011.  A Statement of Compatibility with Human Rights follows.

Finalisation of Investigation

7.             The determining of this Instrument finalises the investigation in relation to sarcoidosis as advertised in the Government Notices Gazette of 4 September 2018.

References

8.             A list of references relating to the above condition is available to any person or organisation referred to in subsection 196E(1)(a) to (c) of the VEA.  Any such request must be made in writing to the Repatriation Medical Authority at the following address:

The Registrar

Repatriation Medical Authority

GPO Box 1014

BRISBANE    QLD    4001

 


Statement of Compatibility with Human Rights

(Prepared in accordance with Part 3 of the Human Rights (Parliamentary Scrutiny) Act 2011)

 

Instrument No.:   Amendment Statement of Principles No. 14 of 2019

Kind of Injury, Disease or Death: Sarcoidosis

 

This Legislative Instrument is compatible with the human rights and freedoms recognised or declared in the international instruments listed in section 3 of the Human Rights (Parliamentary Scrutiny) Act 2011.

Overview of the Legislative Instrument

1. This Legislative Instrument is determined pursuant to subsection 196B(8) of the Veterans' Entitlements Act 1986 (the VEA) for the purposes of the VEA and the Military Rehabilitation and Compensation Act 2004 (the MRCA).  Part XIA of the VEA requires the determination of these instruments outlining the factors linking particular kinds of injury, disease or death with service such being determined solely on the available sound medical-scientific evidence.

2. This Legislative Instrument:-

  • facilitates claimants in making, and the Repatriation Commission in assessing, claims under the VEA and the MRCA respectively, by specifying the circumstances in which medical treatment and compensation can be extended to eligible persons who have sarcoidosis;
  • facilitates the review of such decisions by the Veterans' Review Board and the Administrative Appeals Tribunal;
  • includes amended factors and a new definition which the current sound medical-scientific evidence indicates must exist before it can be said that, on the balance of probabilities, sarcoidosis is connected with the circumstances of eligible service rendered by a person;
  • amends Instrument No. 60 of 2016; and
  • reflects developments in the available sound medical-scientific evidence concerning sarcoidosis which have occurred since that earlier instrument was determined. 

3. The Instrument is assessed as being a technical instrument which improves the medico-scientific quality of outcomes under the VEA and the MRCA. 

Human Rights Implications

4. This Legislative Instrument does not derogate from any human rights. It promotes the human rights of veterans, current and former Defence Force members as well as other persons such as their dependents, including:

  • the right to social security (Art 9, International Covenant on Economic, Social and Cultural Rights; Art 26, Convention on the Rights of the Child and Art 28, Convention on the Rights of Persons with Disabilities) by helping to ensure that the qualifying conditions for the benefit are 'reasonable, proportionate and transparent'[1];
  • the right to an adequate standard of living (Art 11, ICSECR; Art 27, CRC and Art 28, CRPD) by facilitating the assessment and determination of social security benefits;
  • the right to the enjoyment of the highest attainable standard of physical and mental health (Art 12, ICSECR and Art 25, CRPD), by facilitating the assessment and determination of compensation and benefits in relation to the treatment and rehabilitation of veterans and Defence Force members;
  • the rights of persons with disabilities by facilitating the determination of claims relating to treatment and rehabilitation (Art 26, CRPD); and
  • ensuring that those rights "will be exercised without discrimination of any kind as to race, colour, sex, language, religion, political or other opinion, national or social origin, property, birth or other status" (Art 2, ICESCR).

Conclusion

This Legislative Instrument is compatible with human rights as it does not derogate from and promotes a number of human rights.

 

Repatriation Medical Authority

 

 

 

 

 

 

[1] In General Comment No. 19 (The right to social security), the Committee on Economic, Social and Cultural Rights said (at paragraph 24) this to be one of the elements of ensuring accessibility to social security.

Overview

The Amendment Statement of Principles concerning sarcoidosis (Balance of Probabilities) (No. 14 of 2019) was introduced to address the need for updated medical criteria for sarcoidosis in the context of veterans' entitlements and military rehabilitation. This amendment, enacted by the Repatriation Medical Authority under the Veterans' Entitlements Act 1986 and the Military Rehabilitation and Compensation Act 2004, was made to incorporate the latest medical-scientific evidence concerning sarcoidosis, a chronic inflammatory disease that affects multiple organs. The policy objective is to ensure that the qualifying conditions for benefits are reasonable, proportionate, and transparent, thereby facilitating the assessment and determination of claims and the provision of social security, healthcare, and compensation to veterans and Defence Force members affected by sarcoidosis. The instrument promotes various human rights, including the right to social security, an adequate standard of living, and the highest attainable standard of physical and mental health, without discrimination.

Scope and Application

The Amendment Statement of Principles concerning sarcoidosis (Balance of Probabilities) (No. 14 of 2019) pertains to the Veterans' Entitlements Act 1986 and the Military Rehabilitation and Compensation Act 2004. It applies to veterans, current and former Defence Force members, and their dependents who are making claims or have claims assessed for conditions related to sarcoidosis. The amendment specifically revises the factors for determining whether sarcoidosis is connected to the circumstances of service, including the introduction of a new definition of 'specified list of drugs'. This instrument also facilitates the review of such decisions by the Veterans' Review Board and the Administrative Appeals Tribunal. The legislative instrument reflects the latest medical-scientific evidence concerning sarcoidosis and aims to improve the quality of outcomes under the two Acts. Its scope is national, and it does not introduce any exclusions, exemptions, or thresholds beyond those already outlined in the Acts. The instrument is considered a technical amendment that promotes various human rights, including the right to social security and the highest attainable standard of physical and mental health, without derogation from any human rights.

Key Provisions

The Amendment Statement of Principles concerning sarcoidosis (Balance of Probabilities) (No. 14 of 2019) amends the existing Statement of Principles concerning sarcoidosis (Balance of Probabilities) (No. 60 of 2016). The primary changes involve the replacement of existing factors in subsections 9(1) and 9(3) concerning 'being treated with a drug', and the insertion of a new definition of 'specified list of drugs' in Schedule 1 – Dictionary (sections 1 and 2). These amendments aim to reflect recent developments in sound medical-scientific evidence related to sarcoidosis and to facilitate the assessment and determination of claims under the Veterans' Entitlements Act 1986 (VEA) and the Military Rehabilitation and Compensation Act 2004 (MRCA). The instrument also specifies a day of commencement for the amendment in accordance with subsection 12(3) of the Legislation Act 2003 (section 4). The Act imposes specific obligations on parties and entities governed by it, particularly in relation to the assessment and determination of claims for sarcoidosis. The Repatriation Medical Authority (the Authority) must ensure that the amended Statement of Principles accurately reflects current sound medical-scientific evidence and facilitates the assessment process for claimants. The Repatriation Commission and the Military Rehabilitation and Compensation Commission are also obligated to use the updated principles in their assessments, ensuring that the determination of claims is based on the most recent evidence available. Furthermore, the Veterans' Review Board and the Administrative Appeals Tribunal must review such decisions in light of these updated principles, ensuring that the review process is informed by the latest medical-scientific understanding of sarcoidosis (sections 1 and 2). Any breach of the provisions set out in the Amendment Statement of Principles could result in legal consequences. However, the document does not specify particular offences, penalties, or civil/criminal consequences for non-compliance. The focus of the legislation is on the technical and procedural improvements to the assessment and determination of claims for sarcoidosis, rather than on punitive measures for non-compliance. It is essential for all parties involved to adhere to the updated principles to ensure that the claims process remains fair, transparent, and evidence-based. The compatibility of the instrument with human rights is affirmed, highlighting its role in promoting the rights of veterans, current and former Defence Force members, and their dependents (section 6).

Legal classification tags

Area of Law
Veterans' Law
Instrument
Amendment
Concepts
Definitions & Interpretation
Repeal & Amendment
Human Rights Law
Consultation Requirements
Catchwords
Statement of Principles
Compatibility with Human Rights

Interactions

Authorises

All Versions

Sourced from the Federal Register of Legislation at 26 August 2026. For the latest information on Australian Government law please go to https://www.legislation.gov.au.